{{Rsnum
|rsid=3128917
|Gene=HLA-DPA2
|Chromosome=6
|position=33092219
|Orientation=plus
|GMAF=0.3825
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 7.1 | 36.3 | 56.6
| HCB | 20.4 | 51.8 | 27.7
| JPT | 35.4 | 42.5 | 22.1
| YRI | 42.2 | 42.9 | 15.0
| ASW | 22.8 | 45.6 | 31.6
| CHB | 20.4 | 51.8 | 27.7
| CHD | 29.4 | 50.5 | 20.2
| GIH | 6.9 | 37.6 | 55.4
| LWK | 22.7 | 47.3 | 30.0
| MEX | 5.2 | 29.3 | 65.5
| MKK | 16.7 | 43.6 | 39.7
| TSI | 7.8 | 43.1 | 49.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24465836
|Title=Genetic association of human leukocyte antigens with chronicity or resolution of hepatitis B infection in thai population
|OA=1
}}

{{PMID Auto
|PMID=23449268
|Title=HLA-DP and IL28B polymorphisms: influence of host genome on hepatitis B surface antigen seroclearance in chronic hepatitis B.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}